MetaCap

BridgeBio Oncology Therapeutics Insider Trades

NASDAQ: BBOTHealth CareBiotechnology: Pharmaceutical PreparationsUSD

1.81-0.05 (-2.69%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
0 · $0
Sales
2 · $3.63K
Shares bought / sold
0 / 1.95K
Net activity
Net selling $3,628

BridgeBio Oncology Therapeutics insider activity

Over the last 12 months, BridgeBio Oncology Therapeutics insiders reported 23 transactions on SEC Form 4: 0 open-market purchases and 2 sales. Insiders bought $0 and sold $3,628 worth of stock, for net insider selling of $3,628. The largest seller was Beltran Pedro, with $3,443 in reported sales.

The most recent filing shows Beltran Pedro (President and CEO) selling 1,870 shares at $1.84 on Nov 18, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put BBOT's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

BBOT insider transactions

BridgeBio Oncology Therapeutics insider transactions
DateInsiderTypeSharesValueFiling
Nov 18, 2026Beltran PedroPresident and CEOSale1,870$3.44KForm 4
Nov 13, 2026Cobo MarcPrincipal Accounting OfficerSale78$184.86Form 4
Oct 21, 2026Cobo MarcPrincipal Accounting OfficerTax withholding203$544.04Form 4
Oct 1, 2026Beltran PedroPresident and CEOTax withholding1,047$4.13KForm 4
Oct 1, 2026Ben YongChief Med & Dev OfficerTax withholding1,047$4.13KForm 4
Oct 1, 2026Elmelech IdanCOO & Principal Financial OfcrTax withholding343$1.35KForm 4
Oct 1, 2026Cobo MarcPrincipal Accounting OfficerTax withholding126$496.44Form 4
Sep 10, 2026Cobo MarcPrincipal Accounting OfficerTax withholding203$1.12KForm 4
Sep 10, 2026Cobo MarcPrincipal Accounting OfficerAward9,038—Form 4
Jul 1, 2026Beltran PedroPresident and CEOTax withholding1,047$8.17KForm 4
Jul 1, 2026Ben YongChief Med & Dev OfficerTax withholding1,047$8.17KForm 4
Jul 1, 2026Elmelech IdanCOO & Principal Financial OfcrTax withholding343$2.68KForm 4
Jul 1, 2026Chen BihuaDirectorother130,865—Form 4
Jul 1, 2026Chen BihuaDirectorother1,704,862—Form 4
Jul 1, 2026Chen BihuaDirectorother2,692,459—Form 4
Jul 1, 2026Chen BihuaDirectorother4,528,186—Form 4
Jul 1, 2026Cobo MarcPrincipal Accounting OfficerTax withholding125$975Form 4
Apr 1, 2026Mehra UneekFormer OfficerTax withholding524$4.73KForm 4
Apr 1, 2026Beltran PedroPresident and CEOTax withholding1,047$9.45KForm 4
Apr 1, 2026Ben YongChief Med & Dev OfficerTax withholding1,047$9.45KForm 4
Mar 10, 2026Ben YongChief Med & Dev OfficerAward46,670—Form 4
Mar 10, 2026Mehra UneekChief Financial OfficerAward23,330—Form 4
Mar 10, 2026Beltran PedroChief Scientific OfficerAward46,670—Form 4
Oct 10, 2025BridgeBio Pharma LLC & BridgeBio Pharma, Inc.10% Ownerother784,720—Form 4
Aug 11, 2025Chen BihuaDirectorAward284,571—Form 4
Aug 11, 2025Chen BihuaDirectorAward1,762,760—Form 4
Aug 11, 2025Chen BihuaDirectorAward1,905,046—Form 4
Aug 11, 2025Chen BihuaDirectorAward5,598,425$60.00MForm 4
Aug 11, 2025Chen BihuaDirectorAward639,110$6.85MForm 4
Aug 11, 2025Chen BihuaDirectorAward760,496$8.15MForm 4
Aug 11, 2025Chen BihuaDirectorDisposition152,940—Form 4
Aug 11, 2025Chen BihuaDirectorOption exercise4,172,126—Form 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related